低剖面胃造瘻管市场按产品、置入方法、材料、年龄层、应用、尺寸和最终用户划分－全球预测，2026-2032年

2025 年低位胃造瘻管市场价值为 5.8524 亿美元，预计到 2026 年将成长至 6.1246 亿美元，预计到 2032 年将达到 8.4806 亿美元，复合年增长率为 5.44%。

关键市场统计数据
基准年 2025	5.8524亿美元
预计年份：2026年	6.1246亿美元
预测年份 2032	8.4806亿美元
复合年增长率 (%)	5.44%

全面审视影响低调胃造瘻管领域的临床需求、营运驱动因素和相关人员优先事项

低位胃造瘻管在现代经肠营养策略中发挥核心作用，它连接了医院、诊所和居家照护环境，其设计旨在实现持续通畅、提高患者舒适度并最大限度降低併发症风险。临床医师和采购负责人越来越重视那些易于插入、位置稳固、材料生物相容性好，且能够实现从急性期到慢性期连续护理的设备特性。本文阐述了低位胃造瘻管在临床工作流程中的地位，并重点介绍了影响产品选择和应用的跨职能因素。

临床、材料和护理服务的变革性变化正在重新定义经肠营养通路装置的产品设计、推广路径和供应链优先事项。

近年来，临床创新、不断发展的医疗服务模式以及对以患者为中心的治疗结果的日益重视，推动了低位胃造瘻管领域的变革性发展。微创留置技术和装置固定机制的改进增强了医护人员的信心，并使肠内营养管理得以在更广泛的临床环境中应用。同时，材料科学的进步使得聚氨酯和硅胶等新型材料具有更高的抗拉强度和生物相容性，从而延长了使用寿命，并降低了刺激和感染风险。

由于 2025 年实施的累积关税政策，供应链重组已经重塑了设备利害关係人的筹资策略、国内采购奖励和总成本考量。

美国2025年实施的关税调整的累积影响，为胃造瘻管价值链带来了可衡量的限制和机会。关税变化改变了依赖进口原材料和零件的製造商的投入成本结构，促使他们重新评估筹资策略、实现供应商多元化并调整预购做法。为此，一些製造商加快了关键投入品的在地采购或重新谈判供应合约以缓解利润压力，而另一些製造商则致力于产品重新设计，以减少对关税敏感材料的依赖。

详细的細項分析揭示了产品类型、临床环境、留置技术、材料、患者人口统计特征、应用、通路和尺寸如何驱动不同的需求模式

细緻的市场细分观点揭示了需求驱动因素和市场接受度因产品组合、终端用户环境、留置技术、材料成分、患者年龄、临床应用、通路和器械尺寸而异。球囊固定式和固定式器械之间的产品细分突显了易于更换和长期稳定性之间的权衡，这会影响临床医生根据预期治疗时间和手术环境做出的选择。终端使用者包括门诊中心、居家医疗、医院（每家医院又细分为不同的子类型，例如社区医院和教学医院）以及专科诊所，每种环境对员工培训、库存水准和术后支援都有其独特的要求。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太地区的监管协调、报销途径、临床医生采纳情况以及供应链策略。

区域趋势对监管路径、报销框架、临床实务规范和供应链结构有显着影响，从而塑造出差异化的市场进入策略。在美洲，临床应用趋势与门诊服务的扩展、支付主导的成本控制倡议以及对器械耐用性和上市后证据的高度重视密切相关，而这些因素正是报销和采购决策的依据。服务该地区的製造商通常会优先考虑监管合规、建立全国经销伙伴以及开展培训项目，以促进从住院治疗过渡到居家治疗。

深入洞察竞争考察和营运模式的公司，重点关注临床证据、设计创新和经销伙伴，以推动差异化应用和商业性韧性。

医疗设备製造商、契约製造製造商、经销商和服务供应商之间的竞争主要集中在以下几个方面：提高药物保留机制、材料科学和支援服务的创新，以实现更安全、更便捷的长期肠内营养途径。那些优先考虑临床证据产生、高效医护人员培训和上市后监测的公司，在确保产品列入医院处方集和签订长期采购合约方面具有优势。製造商与大型经销商或集团采购组织之间的策略联盟已成为加速市场渗透和实现医疗机构产品供应标准化的常见手段。

为製造商和相关人员制定可操作的策略重点，以透过创新和价值链整合来提升韧性、促进临床应用并创造差异化价值。

产业领导者应优先考虑协作模式，将产品创新、供应链韧性和与医疗服务提供者的合作相结合，以推动产品普及并维持利润率。投资材料研究，优化聚氨酯和硅胶配方，以提高其长期生物相容性并减少併发症，既能满足医疗服务提供者和患者的需求，又能帮助企业在采购谈判中脱颖而出。同时，加强与国内和区域供应商的关係可以降低关税风险，提高对需求波动的应对力，并实现更可预测的前置作业时间和品管。

采用稳健的混合方法研究途径，结合临床文献、相关人员访谈、设备规格和情境分析，以获得可操作的见解。

本分析整合了官方监管指南、同行评审的临床文献、製造商技术规范、采购政策以及相关人员访谈，以全面了解低轮廓胃造瘻管。资料收集结合了来自临床医生、供应链专家和采购人员的定性信息，以及对设备设计、材料和置入技术的技术评估。证据综合强调了同侪审查的结果和上市后安全性报告，以支持商业性应用与临床实际情况的结合。

总之，这项综合分析强调了产品创新、临床检验和供应链策略的整合，以促进经肠营养获取的成果和推广。

低调的胃造瘻管市场呈现出稳定的临床需求、不断演变的器材设计要求以及强调整合解决方案和供应链韧性的商业性趋势。从急诊医院到居家医疗，相关人员都认同以下优先事项：简化置入和维护、材料生物相容性以及可靠的售后支持，从而减少併发症和非计划性治疗。这些优先事项正在影响创新流程和采购标准，并促使製造商在产品性能、服务和培训之间取得平衡。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 低剖面胃造瘻管市场（依产品划分）

• 球囊保留
• 固定保留

9. 低剖面胃造瘻管市场依安装方式划分

• 内视镜
• 放射学
• 外科

第十章 低剖面胃造瘻管市场（依材料分类）

• 聚氨酯
• 硅酮

第十一章 低轮廓胃造瘻管市场依年龄组别划分

• 成人版
• 老年人
• 儿童

第十二章 低剖面胃造瘻管市场依应用领域划分

• 癌症
• 神经系统疾病

13. 低剖面胃造瘻管市场（依尺寸划分）

• 12 Fr
• 14 Fr
• 16 Fr
• 18 Fr

第十四章 低剖面胃造瘻管市场（依最终使用者划分）

• 门诊治疗中心
• 居家医疗
• 医院
• 专科诊所

15. 低剖面胃造瘻管市场（依地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十六章 低剖面胃造瘻管市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

17. 各国低剖面胃造瘻管市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章：美国低轮廓胃造瘻管市场

第十九章 中国低剖面胃造瘻管市场

第20章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Abbott Laboratories
• Amsino International, Inc.
• Applied Medical Technology, Inc.
• Avanos Medical, Inc.
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• ConMed Corporation
• Cook Group, Inc.
• Danone SA
• Degania Silicone Ltd.
• Fresenius Kabi AG
• GBUK Group Limited
• Medinova Endosys Private Limited
• Medline Industries, Inc.
• Nestle Health Science SA
• Poly Medicure Limited
• Silmag Medical Devices Pvt. Ltd.
• Vesco Medical
• Vygon SA

The Low Profile Gastrostomy Tube Market was valued at USD 585.24 million in 2025 and is projected to grow to USD 612.46 million in 2026, with a CAGR of 5.44%, reaching USD 848.06 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 585.24 million
Estimated Year [2026]	USD 612.46 million
Forecast Year [2032]	USD 848.06 million
CAGR (%)	5.44%

Comprehensive introduction framing clinical necessity, operational drivers, and cross-stakeholder priorities shaping the low profile gastrostomy tube landscape

Low profile gastrostomy tubes occupy a central role in modern enteral feeding strategies, bridging hospital, clinic, and home care settings with devices engineered for sustained access, patient comfort, and minimized complication risk. Clinicians and procurement leaders increasingly prioritize device attributes that deliver ease of placement, secure retention, and material biocompatibility while enabling continuity of care across acute and chronic care pathways. This introduction situates low profile gastrostomy tubes within clinical workflows and highlights the cross-functional considerations that shape product selection and adoption.

The device's clinical significance is amplified by demographic shifts and evolving care models that emphasize outpatient management and home-based nutrition. As placement techniques advance and multidisciplinary care teams refine protocols, device performance requirements extend beyond immediate functionality to include long-term durability, infection control, and patient-centered features that support quality of life. Alongside clinical drivers, regulatory oversight and reimbursement frameworks continue to influence procurement decisions, underscoring the need for coordinated evidence generation and stakeholder education. This introduction frames the subsequent analysis by outlining the core clinical, operational, and commercial forces that define the landscape for low profile gastrostomy tubes.

Transformative clinical, material, and care delivery shifts that are redefining product design, adoption pathways, and supply chain priorities for enteral access devices

Recent years have produced transformative shifts across the low profile gastrostomy tube landscape driven by clinical innovation, evolving care delivery models, and heightened attention to patient-centered outcomes. Minimally invasive placement techniques and refinements in device retention mechanisms have expanded clinician confidence, enabling a broader set of care settings to manage enteral access. Concurrently, materials science advances have yielded polyurethane and silicone options with improved tensile strength and biocompatibility, supporting extended use while mitigating irritative and infection risks.

Care delivery has shifted toward ambulatory and home-based management, prompting manufacturers to prioritize ease of handling, simplified maintenance, and compatibility with telehealth-assisted training programs. Regulatory bodies and payer systems are aligning incentives to support reduced inpatient stays, which reinforces demand for devices optimized for outpatient use. In parallel, digital health integration and supply chain resilience have become defining priorities, with stakeholders seeking products that align with standardized inventory management, remote monitoring, and evidence-based protocols. These converging dynamics are reshaping product design, commercialization strategies, and the operational expectations of providers and caregivers.

Cumulative 2025 tariff-driven supply chain realignments that reshaped procurement strategies, domestic sourcing incentives, and total cost considerations for device stakeholders

The cumulative impact of United States tariff adjustments implemented in 2025 has introduced measurable constraints and opportunities across the gastrostomy tube value chain. Tariff changes altered input cost structures for manufacturers that rely on imported raw materials and subcomponents, prompting adjustments to procurement strategies, supplier diversification, and forward-buying practices. In response, some manufacturers accelerated localization of critical inputs or renegotiated supply contracts to mitigate margin pressure, while others pursued product redesign to reduce dependence on tariff-exposed materials.

For distributors and hospital purchasing teams, higher landed costs translated into tighter procurement negotiations and renewed emphasis on total cost of ownership versus unit price alone. This shift incentivized long-term contracts, group purchasing collaborations, and greater scrutiny of logistics and inventory carrying costs. Clinicians and health systems experienced indirect effects as formulary decisions and device selections increasingly considered durability and complication avoidance to offset higher replacement expenses. On the upside, tariff-driven supply chain recalibration stimulated investment in domestic manufacturing capacity and quality assurance processes, creating opportunities for near-shore partners and contract manufacturers positioned to meet regulatory compliance and speed-to-market expectations. Overall, the tariff environment in 2025 catalyzed strategic realignment across manufacturing, distribution, and procurement without fundamentally altering clinical performance requirements.

Granular segmentation analysis revealing how product types, clinical settings, placement techniques, materials, patient cohorts, applications, channels, and sizes drive divergent demand patterns

A nuanced segmentation lens reveals differentiated demand drivers and adoption vectors that vary by product configuration, end-user environment, placement technique, material composition, patient age, clinical application, distribution pathway, and device size. Product segmentation between balloon retention and fixed retention devices highlights trade-offs between ease of replacement and long-term stability, influencing clinician preference depending on anticipated duration of therapy and procedural setting. End users encompass ambulatory care centers, home healthcare, hospitals-each with distinct subprofiles such as community hospitals and teaching hospitals-and specialty clinics, and each setting imposes unique requirements for staff training, inventory depth, and post-placement support.

Placement method segmentation across endoscopic, radiologic, and surgical techniques underscores procedural workflow differences that affect device selection criteria, with endoscopic and radiologic approaches commonly favored for minimally invasive access while surgical methods remain relevant for complex anatomies. Material segmentation differentiates polyurethane and silicone, each offering specific flexibility, bioresistance, and tactile handling characteristics that influence clinician choice and patient comfort. Age group segmentation across adult, geriatric, and pediatric populations requires tailored size selection and care protocols to address anatomical and developmental considerations. Application segmentation for indications such as cancer and neurological disorders highlights diverse nutritional and care continuity needs, often necessitating interdisciplinary coordination. Distribution channel segmentation spans direct sales, distributors-including group purchasing organizations and medical device distributors-online retail, and retail pharmacies, shaping procurement cadence, negotiation leverage, and post-sale service models. Size segmentation across 12 Fr, 14 Fr, 16 Fr, and 18 Fr further aligns device selection to clinical requirements and feeding formulations. Synthesizing these intersecting segments enables a refined view of product development priorities, clinical education focus areas, and commercial strategies that must be calibrated to each segment's operational realities.

Region-specific dynamics shaping regulatory alignment, reimbursement pathways, clinician adoption, and supply chain strategies across Americas, EMEA, and Asia-Pacific

Regional dynamics exert a strong influence on regulatory pathways, reimbursement frameworks, clinical practice norms, and supply chain configurations, shaping differentiated strategies for market engagement. In the Americas, clinical adoption trends are closely tied to outpatient care expansion, payer-driven cost containment initiatives, and a strong emphasis on device durability and post-market evidence that supports reimbursement and procurement decisions. Manufacturers serving the region often prioritize regulatory alignment, domestic distribution partnerships, and training programs that facilitate transition from inpatient to home-based management.

In Europe, Middle East & Africa, variability in national regulations, procurement practices, and hospital purchasing models requires adaptable regulatory and commercial strategies. Adoption in this region is shaped by clinician networks, regional tenders, and the need for robust clinical data to support formulary inclusion across diverse health systems. Manufacturers and distributors frequently tailor product offerings and service bundles to meet specific national requirements and to address infrastructure heterogeneity. In the Asia-Pacific region, demographic trends, rapid expansion of healthcare infrastructure, and growing home healthcare capabilities create significant demand potential, but stakeholders must navigate local manufacturing expectations, cost sensitivity, and variable regulatory timelines. Across all regions, supply chain resilience, localized training, and evidence generation remain central to sustained adoption and market access.

Competitive and operational company insights emphasizing clinical evidence, design innovation, and distribution partnerships that drive differentiated adoption and commercial resilience

Competitive dynamics among device manufacturers, contract manufacturers, distributors, and service providers center on innovation in retention mechanisms, material science, and support services that enable safer, more convenient long-term enteral access. Companies that prioritize clinical evidence generation, streamlined clinician training, and post-market surveillance are better positioned to secure hospital formularies and long-term procurement agreements. Strategic alliances between manufacturers and large distributors or group purchasing organizations have become a common mechanism to accelerate market penetration and standardize product availability across care settings.

Operational excellence in manufacturing quality, regulatory compliance, and supply chain transparency differentiates market leaders from smaller entrants. Investment in human factors engineering and patient-centric design increases product stickiness among outpatient and home-care cohorts, while robust customer support and clinician education programs reduce complication rates and device churn. Several firms are expanding service capabilities, including equipment leasing models and bundled training, to create integrated value propositions. Firms that combine clinical credibility, scalable quality systems, and flexible commercial models will likely sustain competitive advantage as providers emphasize integrated solutions that reduce total cost and improve patient outcomes.

Actionable strategic priorities for manufacturers and stakeholders to drive resilience, clinical adoption, and differentiated value through innovation and supply chain alignment

Industry leaders should prioritize a coordinated approach that aligns product innovation, supply chain resilience, and clinician engagement to accelerate adoption and preserve margin integrity. Investing in materials research to optimize polyurethane and silicone formulations for long-term biocompatibility and reduced complication profiles will address clinician and patient priorities while supporting differentiation in procurement discussions. Concurrently, strengthening domestic and near-shore supplier relationships can mitigate exposure to tariff volatility and improve responsiveness to demand fluctuations, enabling more predictable lead times and quality control.

Commercial strategies should focus on tailored engagement by end-user segment; hospital systems, ambulatory centers, home healthcare providers, and specialty clinics each require distinct value propositions centered on training, service, and total cost implications. Prioritize partnerships with distributors and group purchasing organizations where scale advantages are critical, and develop digital tools and educational resources to support remote training and caregiver competency. Finally, adopt a data-centric posture by investing in post-market surveillance, real-world evidence collection, and outcomes measurement to substantiate clinical value, support reimbursement conversations, and guide continuous product improvement. This integrated strategy will enhance competitive positioning and align product portfolios with evolving care delivery models.

Robust mixed-methods research approach combining clinical literature, stakeholder interviews, device specifications, and scenario analysis to produce actionable insights

This analysis synthesized public regulatory guidance, peer-reviewed clinical literature, manufacturer technical specifications, procurement policies, and stakeholder interviews to assemble a comprehensive perspective on low profile gastrostomy tubes. Data collection combined qualitative inputs from clinicians, supply chain professionals, and procurement leaders with technical evaluations of device design, materials, and placement methodologies. Evidence synthesis emphasized peer-reviewed outcomes and post-market safety reports to ground commercial implications in clinical reality.

Analytical methods included cross-segmentation mapping to reconcile device attributes with end-user needs, region-specific regulatory review to identify access barriers, and scenario-based impact assessment for supply chain shocks such as tariff adjustments. Validation steps incorporated expert reviews and reconciliation of divergent stakeholder perspectives to ensure findings reflected operational constraints and adoption drivers. The methodology prioritized transparency in source attribution and applied conservative interpretation of secondary reports, focusing on reproducible insights that support strategic planning and operational decision-making.

Concluding synthesis emphasizing integration of product innovation, clinical validation, and supply chain strategy to advance enteral access outcomes and adoption

The low profile gastrostomy tube landscape is characterized by steady clinical demand, evolving device design imperatives, and shifting commercial dynamics that favor integrated solutions and supply chain resilience. Across settings from acute hospitals to home care, stakeholders are converging on priorities that include simplified placement and maintenance, material biocompatibility, and reliable post-market support that reduces complications and unplanned care. These priorities are shaping innovation pipelines and procurement criteria alike, encouraging manufacturers to balance product performance with service and training offerings.

Looking ahead, sustained emphasis on outpatient care delivery, clinician education, and evidence generation will determine which products achieve broad adoption and long-term formulary inclusion. Organizations that align clinical validation with operational reliability and commercially viable distribution strategies will be best able to meet provider needs and support patient-centered care pathways. The conclusion synthesizes these themes into a clear imperative: integrating product innovation, supply chain strategy, and clinical engagement is essential to advance enteral access care and to deliver measurable improvements in patient outcomes and system efficiency.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Low Profile Gastrostomy Tube Market, by Product

• 8.1. Balloon Retention
• 8.2. Fixed Retention

9. Low Profile Gastrostomy Tube Market, by Placement Method

• 9.1. Endoscopic
• 9.2. Radiologic
• 9.3. Surgical

10. Low Profile Gastrostomy Tube Market, by Material

• 10.1. Polyurethane
• 10.2. Silicone

11. Low Profile Gastrostomy Tube Market, by Age Group

• 11.1. Adult
• 11.2. Geriatric
• 11.3. Pediatric

12. Low Profile Gastrostomy Tube Market, by Application

• 12.1. Cancer
• 12.2. Neurological Disorders

13. Low Profile Gastrostomy Tube Market, by Size

• 13.1. 12 Fr
• 13.2. 14 Fr
• 13.3. 16 Fr
• 13.4. 18 Fr

14. Low Profile Gastrostomy Tube Market, by End User

• 14.1. Ambulatory Care Centers
• 14.2. Home Healthcare
• 14.3. Hospitals
• 14.4. Specialty Clinics

15. Low Profile Gastrostomy Tube Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Low Profile Gastrostomy Tube Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Low Profile Gastrostomy Tube Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. United States Low Profile Gastrostomy Tube Market

19. China Low Profile Gastrostomy Tube Market

20. Competitive Landscape

• 20.1. Market Concentration Analysis, 2025
  • 20.1.1. Concentration Ratio (CR)
  • 20.1.2. Herfindahl Hirschman Index (HHI)
• 20.2. Recent Developments & Impact Analysis, 2025
• 20.3. Product Portfolio Analysis, 2025
• 20.4. Benchmarking Analysis, 2025
• 20.5. Abbott Laboratories
• 20.6. Amsino International, Inc.
• 20.7. Applied Medical Technology, Inc.
• 20.8. Avanos Medical, Inc.
• 20.9. B. Braun Melsungen AG
• 20.10. Boston Scientific Corporation
• 20.11. Cardinal Health, Inc.
• 20.12. ConMed Corporation
• 20.13. Cook Group, Inc.
• 20.14. Danone S.A.
• 20.15. Degania Silicone Ltd.
• 20.16. Fresenius Kabi AG
• 20.17. GBUK Group Limited
• 20.18. Medinova Endosys Private Limited
• 20.19. Medline Industries, Inc.
• 20.20. Nestle Health Science S.A.
• 20.21. Poly Medicure Limited
• 20.22. Silmag Medical Devices Pvt. Ltd.
• 20.23. Vesco Medical
• 20.24. Vygon S.A.

LIST OF FIGURES

• FIGURE 1. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 13. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 14. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 15. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY BALLOON RETENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY BALLOON RETENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY BALLOON RETENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY FIXED RETENTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY FIXED RETENTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY FIXED RETENTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 12 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 14 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 16 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY 18 FR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 71. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 72. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 73. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 74. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 75. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 77. AMERICAS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 78. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 80. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 81. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 82. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 83. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 84. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 85. NORTH AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 86. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 87. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 88. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 89. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 90. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 91. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 92. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 93. LATIN AMERICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 95. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 96. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 102. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 104. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 105. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 107. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 108. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 109. EUROPE LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 110. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 111. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 112. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 113. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 114. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 115. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 116. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 117. MIDDLE EAST LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 119. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 120. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 121. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 122. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 123. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 124. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 125. AFRICA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 126. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 127. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 128. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 129. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 130. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 131. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 132. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 133. ASIA-PACIFIC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 134. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 135. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 137. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 138. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 139. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 140. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 141. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 142. ASEAN LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 143. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 144. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 145. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 146. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 147. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 148. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 149. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 150. GCC LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 151. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 152. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 153. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 154. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 155. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 156. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 157. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 158. EUROPEAN UNION LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 159. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 160. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 161. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 162. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 163. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 164. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 165. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 166. BRICS LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 167. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 168. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 169. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 170. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 171. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 172. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 173. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 174. G7 LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 175. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 176. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 177. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 178. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 179. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 180. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 181. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 182. NATO LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. GLOBAL LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 184. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 185. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 186. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 187. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 188. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 189. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 190. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 191. UNITED STATES LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 192. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 193. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 194. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
• TABLE 195. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 196. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 197. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 198. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
• TABLE 199. CHINA LOW PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)